Verrica Pharmaceuticals (VRCA) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free VRCA Stock Alerts $8.69 +0.02 (+0.23%) (As of 09:36 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Verrica Pharmaceuticals Short Interest DataCurrent Short Volume3,620,000 sharesPrevious Short Volume3,840,000 sharesChange Vs. Previous Month-5.73%Dollar Volume Sold Short$25.21 millionShort Interest Ratio / Days to Cover23.6Last Record DateApril 30, 2024Outstanding Shares42,420,000 sharesFloat Size25,770,000 sharesShort Percent of Float14.05%Today's Trading Volume3,600 sharesAverage Trading Volume181,050 sharesToday's Volume Vs. Average2% Short Selling Verrica Pharmaceuticals ? Sign up to receive the latest short interest report for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVRCA Short Interest Over TimeVRCA Days to Cover Over TimeVRCA Percentage of Float Shorted Over Time Ad Timothy SykesBill Gates is all about this tiny $2 stockWhat does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthless $2 stock…>>Click here to discover why Bill Gates is all about this tiny $2 stock. Verrica Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,620,000 shares $25.21 million -5.7%14.1%23.6 $6.97 4/15/20243,840,000 shares $26.57 million -8.1%15.1%28.3 $6.92 3/31/20244,180,000 shares $24.75 million -5.0%16.5%28.2 $5.92 3/15/20244,400,000 shares $21.12 million -0.7%17.4%22.4 $4.80 2/29/20244,430,000 shares $23.35 million +1.1%17.4%4.1 $5.27 2/15/20244,380,000 shares $24.35 million -1.1%17.3%4.1 $5.56 Get the Latest News and Ratings for VRCA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20244,430,000 shares $25.03 million -20.2%17.7%4.1 $5.65 1/15/20245,550,000 shares $31.75 million +5.3%22.1%5.1 $5.72 12/31/20235,270,000 shares $38.58 million +44.4%21.0%4.9 $7.32 12/15/20233,650,000 shares $22.23 million -8.5%14.6%3.4 $6.09 11/30/20233,990,000 shares $14.68 million -6.3%15.9%25 $3.68 11/15/20234,260,000 shares $13.50 million +1.2%17.0%23.9 $3.17 10/31/20234,210,000 shares $15.49 million -2.3%16.7%21.7 $3.68 10/15/20234,310,000 shares $15.73 million -3.8%17.1%15.1 $3.65 9/30/20234,480,000 shares $17.40 million -9.3%17.8%11.8 $3.89 9/15/20234,940,000 shares $20.01 million +1.9%19.6%12.6 $4.05 8/31/20234,850,000 shares $22.07 million +7.5%19.3%11.5 $4.55 8/15/20234,510,000 shares $22.50 million +11.1%17.8%11.1 $4.99 7/31/20234,060,000 shares $23.71 million +34.4%16.0%10.7 $5.84 7/15/20233,020,000 shares $20.20 million +3.8%12.0%9.4 $6.69 6/30/20232,910,000 shares $16.79 million +33.5%11.5%13.3 $5.77 6/15/20232,180,000 shares $13.67 million +6.9%8.6%10.6 $6.27 5/31/20232,040,000 shares $11.57 million +14.6%8.1%13.4 $5.67 5/15/20231,780,000 shares $10.86 million +21.1%7.1%10.9 $6.10 4/30/20231,470,000 shares $9.07 million +55.7%5.9%7.6 $6.17 4/15/2023944,100 shares $5.85 million +60.7%3.8%4.9 $6.20 3/31/2023587,500 shares $3.82 million +94.8%2.4%3 $6.50 3/15/2023301,600 shares $2.01 million +24.8%1.2%1.7 $6.65 2/28/2023241,600 shares $1.87 million -7.5%1.0%1.4 $7.75 2/15/2023261,200 shares $1.97 million +12.1%1.1%1.6 $7.54 1/31/2023233,000 shares $1.08 million -50.7%1.0%1.7 $4.62 1/15/2023472,500 shares $2.29 million -18.4%2.0%4.2 $4.85 12/30/2022579,300 shares $1.59 million -7.9%2.4%5.9 $2.75 12/15/2022629,000 shares $1.98 million -4.2%2.6%8.1 $3.14 11/30/2022656,300 shares $2.13 million -5.7%2.7%6.6 $3.25 11/15/2022695,800 shares $1.59 million +6.0%2.9%7.1 $2.28 10/31/2022656,300 shares $1.63 million +7.0%2.7%6.5 $2.49 10/15/2022613,200 shares $1.67 million -1.9%2.6%5.7 $2.73 9/30/2022625,100 shares $1.83 million -19.6%2.6%4.5 $2.92 9/15/2022777,900 shares $2.96 million -9.8%3.2%2.4 $3.80Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now VRCA Short Interest - Frequently Asked Questions What is Verrica Pharmaceuticals' current short interest? Short interest is the volume of Verrica Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 3,620,000 shares of VRCA short. 14.05% of Verrica Pharmaceuticals' shares are currently sold short. Learn More on Verrica Pharmaceuticals' current short interest. What is a good short interest ratio for Verrica Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VRCA shares currently have a short interest ratio of 24.0. Learn More on Verrica Pharmaceuticals's short interest ratio. What is a good short interest percentage for Verrica Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.05% of Verrica Pharmaceuticals' floating shares are currently sold short. Is Verrica Pharmaceuticals' short interest increasing or decreasing? Verrica Pharmaceuticals saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 3,620,000 shares, a decline of 5.7% from the previous total of 3,840,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Verrica Pharmaceuticals' float size? Verrica Pharmaceuticals currently has issued a total of 42,420,000 shares. Some of Verrica Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Verrica Pharmaceuticals currently has a public float of 25,770,000 shares. How does Verrica Pharmaceuticals' short interest compare to its competitors? 14.05% of Verrica Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Verrica Pharmaceuticals: Shattuck Labs, Inc. (4.29%), Korro Bio, Inc. (2.68%), Neurogene Inc. (8.85%), Esperion Therapeutics, Inc. (11.79%), Mereo BioPharma Group plc (2.02%), Terns Pharmaceuticals, Inc. (10.91%), Heron Therapeutics, Inc. (18.11%), Organogenesis Holdings Inc. (12.55%), Amarin Co. plc (3.94%), Annexon, Inc. (6.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Verrica Pharmaceuticals stock? Short selling VRCA is an investing strategy that aims to generate trading profit from Verrica Pharmaceuticals as its price is falling. VRCA shares are trading down $0.48 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Verrica Pharmaceuticals? A short squeeze for Verrica Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VRCA, which in turn drives the price of the stock up even further. How often is Verrica Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRCA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: STTK Short Squeeze KRRO Short Squeeze NGNE Short Squeeze ESPR Short Squeeze MREO Short Squeeze TERN Short Squeeze HRTX Short Squeeze ORGO Short Squeeze AMRN Short Squeeze ANNX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRCA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing